The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...

Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with ...

On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...

FDA approves Journavx, a non-opioid medication for moderate to severe acute pain. Learn about its efficacy and side effects.

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...

Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...